Virano Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Virano Therapeutics Inc. - overview
Established
2021
Location
Toronto, ON, Canada
Primary Industry
Biotechnology
About
Founded in 2021 and based in Toronto, Ontario, Canada, Virano Therapeutics Inc. , operates as a biotechnology research company that develops genetic therapies for high-need diseases like cancer. In November 2023, Virano Therapeutics Inc. , raised venture funding from the Fight Against Cancer Innovation Trust.
Virano Therapeutics offers a pipeline of vector potentiators (VEPO) and vector therapies for enhanced gene therapies that are designed to be advanced, effective, and prioritize patient safety. The company engages in in-house discovery efforts to drive the development of innovative gene therapies allowing for the expression of a functional protein focuses on addressing a range of debilitating genetic illnesses. The company plans to use November 2023 to develop and commercialize its new drugs for treating cancer.
Current Investors
Fight Against Cancer Innovation Trust
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.viranotx.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.